Your shopping cart is empty!
Abiraterone is a CYP17 inhibitor indicated in combination with prednisone for the treatment of patients with metastatic castration-resistant prostate cancer.
Tags: Zytiga
Abiraterone Acetate is a CYP17 inhibitor indicated in combination with prednisone for the treatment ..
BDT 580.00